| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NIOX.2009.09.005 |
| P8608 | Fatcat ID | release_ezxiiw7ax5bjbdrhtwqafee7t4 |
| P932 | PMC publication ID | 3390151 |
| P698 | PubMed publication ID | 19800018 |
| P5875 | ResearchGate publication ID | 26866333 |
| P2093 | author name string | Behzad N Oskouei | |
| Carol A Cooke | |||
| Farideh Beigi | |||
| Guillaume Lamirault | |||
| Joshua M Hare | |||
| Meizi Zheng | |||
| P2860 | cites work | Overexpression of sarcolemmal calcium pump attenuates induction of cardiac gene expression in response to ET-1 | Q74379356 |
| Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats | Q77494114 | ||
| Nitric oxide synthase in cardiac sarcoplasmic reticulum | Q22008689 | ||
| Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b | Q24294192 | ||
| CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart | Q24310490 | ||
| Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation | Q24315685 | ||
| CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95 | Q24336329 | ||
| Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. | Q24531397 | ||
| Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON | Q28138253 | ||
| Mechanism and role of PDZ domains in signaling complex assembly | Q28190934 | ||
| Changes in mRNA for post-synaptic density-95 (PSD-95) and carboxy-terminal PDZ ligand of neuronal nitric oxide synthase following facial nerve transection | Q28576091 | ||
| Binding of neuronal nitric-oxide synthase (nNOS) to carboxyl-terminal-binding protein (CtBP) changes the localization of CtBP from the nucleus to the cytosol: a novel function for targeting by the PDZ domain of nNOS | Q28909767 | ||
| NO/redox disequilibrium in the failing heart and cardiovascular system | Q30475784 | ||
| Caveolae and calcium handling, a review and a hypothesis | Q33247811 | ||
| There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling | Q34433389 | ||
| A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization | Q34519498 | ||
| PDZ domains-glue and guide. | Q35169335 | ||
| Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide | Q35169824 | ||
| nNOS at a glance: implications for brain and brawn | Q35787938 | ||
| Cardiac nitric oxide: emerging role for nNOS in regulating physiological function | Q36076327 | ||
| Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations | Q37436202 | ||
| Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling | Q37619331 | ||
| Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study | Q39801396 | ||
| The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex | Q40273656 | ||
| Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. | Q42445556 | ||
| Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium | Q42486752 | ||
| NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. | Q42855743 | ||
| Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms | Q43926534 | ||
| Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. | Q45091717 | ||
| CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy | Q45160710 | ||
| Use of poly(vinylpyrrolidone) and poly(vinyl alcohol) for cryoultramicrotomy | Q46472458 | ||
| nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction | Q46847937 | ||
| Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy | Q46853314 | ||
| Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury | Q46882604 | ||
| Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases | Q47891975 | ||
| Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis | Q48556024 | ||
| Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms | Q59091659 | ||
| Expression of the plasma membrane Ca2+-ATPase in myogenic cells | Q71825447 | ||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Caveolin 3 | Q14901728 |
| Xanthine dehydrogenase | Q15330879 | ||
| Nitric oxide synthase 1 adaptor protein | Q21112908 | ||
| clinical chemistry | Q849994 | ||
| Nitric oxide synthase 1 (neuronal) adaptor protein | Q21497197 | ||
| Nitric oxide synthase 1, neuronal | Q21980042 | ||
| RAS, dexamethasone-induced 1 | Q21990390 | ||
| P304 | page(s) | 226-33 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Nitric Oxide | Q7041392 |
| P1476 | title | Cardiac nitric oxide synthase-1 localization within the cardiomyocyte is accompanied by the adaptor protein, CAPON | |
| P478 | volume | 21 |
| Q84208872 | Alterations in β3-adrenergic cardiac innervation and nitric oxide signaling in heart failure |
| Q35804105 | CAPON modulates neuronal calcium handling and cardiac sympathetic neurotransmission during dysautonomia in hypertension. |
| Q37904883 | Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps |
| Q28075944 | Cardiac sympatho-vagal balance and ventricular arrhythmia |
| Q39103381 | Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology |
| Q38750251 | Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness |
| Q24292961 | NOS1AP modulates intracellular Ca(2+) in cardiac myocytes and is up-regulated in dystrophic cardiomyopathy |
| Q89726591 | NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis |
| Q26859562 | Nitric Oxide Synthase 1 Adaptor Protein, an Emerging New Genetic Marker for QT Prolongation and Sudden Cardiac Death |
| Q38196172 | Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease |
| Q26830146 | Nitric oxide synthases in heart failure |
| Q42668752 | Nitroso-redox imbalance affects cardiac structure and function. |
| Q34878829 | Plasma membrane calcium ATPase proteins as novel regulators of signal transduction pathways |
| Q35842187 | Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain |
| Q37938337 | Sub-cellular targeting of constitutive NOS in health and disease |
| Q39342378 | The Plasma Membrane Calcium ATPases and Their Role as Major New Players in Human Disease |
Search more.